ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Final Issue Of ‘77

December 16, 1977

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

Program Announcement In Preventative Oncology

May 21, 1982

Public Meeting On Ionizing Radiation Set

January 11, 1980

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

CCIRC Members Now Feel At Home In DCT

March 3, 1978